Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book

被引：6
|
作者：
Santos, Raul D. [1 ,2 ]
Rocha, Viviane Z. [1 ]
机构：
[1] Univ Sao Paulo, Med Sch Hosp, Heart Inst InCor, Lipid Clin, Av Dr Eneas C Aguiar 44, BR-05403900 Sao Paulo, Brazil
[2] Hosp Israelita Albert Einstein, Acad Res Org, Sao Paulo, Brazil
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 02期
关键词：
EVOLOCUMAB;
D O I：
10.1093/eurheartj/ehac656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Inclisiran and cardiovascular events: a patient-level analysis of phase III trials, by K.K. Ray et al., https://doi.org/10. 1093/eurheartj/ehac594.
引用
收藏
页码：139 / 141
页数：3
相关论文
共 50 条
  • [21] Beyond LDL Cholesterol, a New Role for PCSK9
    Akram, Omar N.
    Bernier, Adeline
    Petrides, Francine
    Wong, Gida
    Lambert, Gilles
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (07) : 1279 - 1281
  • [22] Inclisiran RNAi therapeutic targeting PCSK9 Treatment of hypercholesterolemia
    Paton, D. M.
    DRUGS OF THE FUTURE, 2017, 42 (06) : 335 - 343
  • [23] LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy
    Hamasaki, Masato
    Sakane, Naoki
    Hara, Kazuo
    Kotani, Kazuhiko
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (11)
  • [24] DRIVERS IN HTA DECISION-MAKING FOR CHOLESTEROL LOWERING PCSK9 INHIBITORS
    Kreeftmeijer, J.
    Dekkers, R.
    van Engen, A.
    VALUE IN HEALTH, 2016, 19 (07) : A603 - A603
  • [25] PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
    Wang, Yan
    Liu, Zhao-Peng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (02) : 165 - 176
  • [26] Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies
    Paryani, Mitali
    Gupta, Nikita
    Jain, Sanjay Kumar
    Butani, Shital
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [27] Cholesterol reduction with PCSK9 inhibitors
    Lambooij A.
    Huisarts en wetenschap, 2018, 61 (9) : 18 - 20
  • [28] Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)
    Sinning, David
    Landmesser, Ulf
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (12)
  • [29] Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)
    David Sinning
    Ulf Landmesser
    Current Cardiology Reports, 2020, 22
  • [30] Lipid-lowering drugs and PCSK9
    Millan Nunez-Cortes, Jesus
    Mostaza Prieto, Jose M.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 : 9 - 13
12345